VI Partners

VI Partners is a well-established venture capital firm based in Altendorf, Switzerland, with a strong dual focus on healthcare and technology sectors. Founded in 2001, the firm has built a significant track record over two decades, investing in innovative early and growth-stage companies primarily across Switzerland and Europe, with selective investments in North America. Their expertise spans a broad range of areas, including biotech, medtech, digital health, as well as ICT, advanced materials, cleantech, robotics, and artificial intelligence.

The firm's investment strategy is characterized by its commitment to supporting companies from their nascent stages through significant growth. VI Partners typically participates in Seed, Series A, and Series B rounds, demonstrating a flexible approach to early-stage funding. They are known for their capacity to provide substantial follow-on capital, often investing up to CHF 15 million or more per company over its lifecycle, helping portfolio companies scale effectively.

VI Partners has consistently raised new funds to support its investment activities. Notably, their fourth fund, VI Partners IV, successfully closed at CHF 120 million, underscoring investor confidence in their strategy and team. More recently, the firm continued its fundraising success with the closing of VI Partners V at CHF 150 million, further solidifying its position as a key player in the European venture capital landscape. Initial investments typically range from CHF 2 million to CHF 5 million, reflecting their focus on providing meaningful early-stage capital.